Fierce Pharma October 11, 2024
A survey of more than 2,000 patients and physicians has painted a rosy picture of the impact of pharma ads, showing that promotions raise awareness of treatment options, drive discovery of health conditions and improve management of existing ailments.
The survey is the result of a collaboration between media intelligence business Magna and advertising platform DeepIntent. Together, the businesses ran online surveys of 1,166 patients and 1,001 doctors to determine whether pharma ads do more than just build brands. Advocates of direct-to-consumer ads argue they have educational value and improve health. The survey gathered data to support that view.
First, Magna and DeepIntent showed pharma ads do their primary job: raising awareness of treatments. Almost two-thirds of patients said they...